Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Stock Picking - 2002 -- Ignore unavailable to you. Want to Upgrade?

To: Dave Gore who wrote (123)	1/4/2002 2:27:01 PM
From: Dave Gore	Read Replies (1) \| Respond to of 308

STOCK BUY: DDDP @ 8.92 - Briefing mention, deal with JNJ. More speculative, so took a small position for my longer term account. I don't see a lot of downside risk based on the chart; stock has retraced about 50% from year highs. News today give me added confidence for good REWARD to RISK performance and gives me access to this sector as a core holding. News: siliconinvestor.com Nov 29 2001 12:20 PM Shorts 3-Dimensional Pharma (DDDP) 8.58 unch: -- Morning Note -- SWS Securities initiates coverage with a Buy rating and price target of $12; says DDDP should be a core holding in the life science informatics sector; company has built a robust technology platform; believes DDDP will benefit from the trend toward greater outsourcing of R&D activity on the part of pharmaceutical and biotech companies; thinks this trend will continue unabated due to the number of targets being generated.